Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03967522
Title Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases (CABRAMET)
Acronym CABRAMET
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de Cancérologie de l'Ouest-Site Paul Papin Angers 49005 France Details
CHU Besancon Besançon 25030 France Details
CHU Bordeaux Bordeaux 33075 France Details
Centre Jean Perrin Clermont-Ferrand 63011 France Details
Centre Leon Berard Lyon 69373 France Details
Institut de Cancérologie de la Lorraine Nancy 54519 France Details
Hopital Européen Georges Pompidou Paris 75015 France Details
Institut de Cancérologie de l'Ouest-site René Gauducheau Saint-Herblain 44805 France Details
ICANS Strasbourg 67000 France Details
Hopital Foch Suresnes 92150 France Details
IUCT-Institut Claudius Regaud Toulouse 31059 France Details
Institut Gustave Roussy Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field